When can a risk factor be used as a worthwhile screening test?

BMJ

Volumn 319, Issue 7224, 1999, Pages 1562-

  Wald, N J ^a   Hackshaw, A K ^a   Frost, C D ^b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DATA ANALYSIS; DIAGNOSTIC ERROR; DISEASE ASSOCIATION; HUMAN; INCIDENCE; METHODOLOGY; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST;

FALSE POSITIVE REACTIONS; HUMANS; MASS SCREENING; ODDS RATIO; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 0033547616     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.319.7224.1562     Document Type: Article

References (3)

1. Wald NJ, Law M, Watt H, Wu T, Bailey A, Johnson M, et al. Apolipoproteins and ischaemic heart disease: Implications for screening. Lancet 1994; 343: 75-79.
2. Wald NJ, Cuckle HS, Densem JW, Kennard A, Smith D. Maternal serum screening for Down'\s syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight. Br J Obstet Gynaecol 1992; 99: 144-149.
3. Wald NJ, Kennard A. Prenatal screening for neural tube defects and Down'\s syndrome. In: Rimoin DL,Connor JM,Pyeritz RE,eds. Emery and Rimoin'\s principles and practice of medical genetics. 3rd ed. Edinburgh: Churchill Livingstone, 1996: 545-562.